Research Article
BibTex RIS Cite

Aşırı Aktif Mesaneli Kadınlarda Pelvik Taban Kas Kuvveti ile Mesane Semptom Ciddiyeti ve Kaygı Düzeyi Arasındaki İlişkisi

Year 2018, Volume: 1 Issue: 2, 1 - 7, 31.01.2019

Abstract

Amaç: Bu çalışmanın amacı, aşırı aktif
mesaneli (AAM) kadınlarda pelvik taban kas kuvveti (PTKK) ile mesane semptom
ciddiyeti ve kaygı düzeyi arasındaki ilişkiyi incelemektir.

Yöntem: AAM tanısı olan 40 kadın çalışmaya
dahil edilmiştir. Hastaların fiziksel ve klinik özellikleri kaydedilmiştir.
Hastaların PTKK’si perineometre cihazı ile, AAM’ye bağlı görülen semptomların
ciddiyeti Aşırı Aktif Mesane-V8 Anketi (AAM-V8) ile, sıkışma hissi Hasta
Sıkışma Hissi Ciddiyet Algısı Ölçeği (HSHCAÖ) ve kaygı düzeyi Spielberger
Durumluk-Sürekli Kaygı Envanteri ile değerlendirilmiştir. Analiz için Pearson
ve Spearman korelasyon testleri kullanılmıştır. 

Bulgular: AAM’li hastalarda PTKK ile
AAM-V8 (p < 0,001; r= -0,568), sıkışma hissi (p= 0,004; rho= -0,447) ve
sürekli kaygı skoru (p= 0,010; r= -0,440) arasında orta derecede negatif ilişki
bulunmuştur. PTKK ile durum kaygı skoru arasında anlamlı bir ilişki
saptanmamıştır (p= 0,451; r= -0,134).

Sonuç: Bu çalışmada, AAM’li kadınlarda
PTKK, AAM ile ilişkili semptomlarının ciddiyeti ve sürekli kaygı düzeyi ile
negatif bir ilişkili olduğu görüldü. AAM semptomları ve kaygı düzeyinin
azalması için bu hastaların tedavisinde PTKK’nin artırılması göz önünde
bulundurulmalıdır.

References

  • 1. Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Neurourol Urodyn. 2010 Jan; 21(1):5-26.
  • 2. Irwin DE, Milsom I, Hunskaar S, Reilly K, Kopp Z, Herschorn S, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol. 2006 Dec; 50(6):1306–14.
  • 3. Milsom I, Abrams P, Cardozo L, Roberts RG, Thüroff J, Wein AJ. How wide spread are the symptoms of the overactive bladder and how are they managed? A population-based study. BJU Int. 2001 Jun; 87(9):760–6.
  • 4. Lugo Salcedo F, Sánchez Borrego R, Bueno ER, Sanz TO, García PB, Munné JG, C, et al. Assessment of female prevalence of overactive bladder (OAB) in Barcelona using a self-administered screening questionnaire: The Cuestionario de Autoevaluación del Control de la Vejiga (CACV). Int Urogynecol J. 2013 Sep; 24(9):1559-66.
  • 5. Mostwin JL. Pathophysiology: The varieties of bladder overactivity. Urology. 2002 Nov; 60(5):22-6.
  • 6. Gunnarsson M, Mattiasson A. Circumvaginal surface electromyography in women with urinary incontinence and in healthy volunteers. Scand J Urol Nephrol Suppl. 1994; 157:89-95.
  • 7. Gunnarsson M, Mattiasson A. Female stress, urge, and mixed urinary incontinence are associated with a chronic and progressive pelvic floor/vaginal neuromuscular disorder: an investigation of 317 healthy and incontinent women using vaginal surface electromyography. Neurourol Urodyn. 1999; 18(6):613-21.
  • 8. Shafik A, Shafik IA. Overactive bladder inhibition in response to pelvic floor muscle exercises. World J Urol. 2003 May; 20(6):374–7
  • 9. Artibani W. Diagnosis and significance of idiopathic overactive bladder. Urology. 1997 Dec; 50(6A Suppl):25–32
  • 10. Bo K, Berghmans LCM. Nonpharmacologic treatment for overactive bladder-pelvic floor exercises. Urology. 2000 May; 55(5A Suppl):7–11
  • 11. Lai H, Gardner V, Vetter J, Andriole GL. Correlation between psychological stress levels and the severity of overactive bladder symptoms. BMC Urol. 2015 Mar; 15:14.
  • 12. Çankaya A, Oskay ÜY. Assessment of bladder diaries of women diagnosed with overactive bladder syndrome. Gulhane Med J. 2014 Sep; 56(3):169-73.
  • 13. Patterson A. Behaviour change to treat overactive bladder syndrome. Nurs Times. 2011 Nov; 107(46):16-9.
  • 14. Freeman RM, Adekanmi OA. Overactive bladder. Best Pract Res Clin Obstet Gynaecol. 2005 Dec; 19(6):829–41.
  • 15. Wang Y, Xu K, Hu H, Zhang X, Wang X, Na Y, et al. Prevalence, risk factors, and impact on health related quality of life of overactive bladder in China. Neurourol Urodyn. 2011 Nov; 30(8):1448-55.
  • 16. Smith AL, Wein AJ. Contemporary management of overactive bladder. Postgrad Med. 2012 Jan; 124(1):104-16.
  • 17. Coyne K, Revicki D, Hunt T, Corey R, Stewart W, Bentkover J, et al. Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-q. Qual Life Res. 2002 Sep; 11(6):563-74.
  • 18. Tarcan T, Mangır N, Özgür MÖ, Akbal C. OAB-V8 aşırı aktif mesane sorgulama formu validasyon çalışması. Üroloji Bülteni. 2012; 21:113-6.
  • 19. Cartwright R, Srikrishna S, Cardozo L, Robinson D. Validity and reliability of the patient's perception of intensity of urgency scale in overactive bladder. BJU Int. 2011 May; 107(10):1612–7.
  • 20. Spielberger CD, Gorsuch RL, Lushene R. Manual for the state-trait anxiety inventory: STAI (“Self-evaluation Questionnaire”). Palo Alto: Consulting Psychologists Press; 1970.
  • 21. Öner N, Le Compte A. Süreksiz Durumluk ve Sürekli Kaygı Envanteri El Kitabı. 2. baskı. İstanbul, Türkiye: Boğaziçi Üniversitesi Yayınları; 1985.
  • 22. Wattanayingcharoenchai R, Manonai J, Vannatim N, Saritapirak S, Imsomboon C, Chittacharoen A. Impact of stress urinary incontinence and overactive bladder on quality of life in Thai women attending the urogynecology clinic. J Med Assoc Thai. 2007 Jan; 90(1):26-31.
  • 23. Lai HH, Rawal A, Shen B, Vetter J. The relationship between anxiety and overactive bladder or urinary incontinence symptoms in the clinical population. Urology. 2016 Dec; 98:50–7.
  • 24. Macaulay AJ, Stern RS, Holmes DM, Stanton SL. Micturition and the mind: psychological factors in the aetiology and treatment of urinary symptoms in women. Br Med J (Clin Res Ed). 1987 Feb; 294(6571):540-3.
  • 25. Melotti IGR, Juliato CRT, Tanaka M, Riccetto CLZ. Severe depression and anxiety in women with overactive bladder. Neurourol Urodyn. 2018 Jan; 37(1):223–8
  • 26. Kupelian V, Wei JT, O’Leary MP, Norgaard JP, Rosen RC, McKinlay JB. Nocturia and quality of life: results from the Boston area community health survey. Eur Urol. 2012 Jan; 61(1):78–84.
  • 27. Alves AT, Jácomo RH, Gomide LB, Garcia PA, Bontempo AP, Karnikoskwi MG. Relationship between anxiety and overactive bladder syndrome in older women. Rev Bras Ginecol Obstet. 2014 Jul; 36(7):1–9.
  • 28. Coyne KS, Sexton CC, Irwin DE, Kopp ZS, Kelleher CJ, Milsom I. The Impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, Work productivity, sexuality and emotional well-being in men and women: results from the EPIC study. BJU Int. 2008 Jun; 101(11):1388–95.
  • 29. Stewart WF, Van Rooyen JB, Cundif GW, Abrams P, Herzog AR, Corey R, et al. Prevalence of burden of overactive bladder in the United States. World J Urol. 2003 May; 20(6):327–36.
  • 30. Milsom I, Kaplan SA, Coyne KS, Sexton CC, Kopp ZS. Effect of bothersome overactivie bladder symptoms on health-related quality of life, anxiety, depression, and treatment seeking in the United States: results from EpiLUTS. Urology. 2012 Jul; 80(1):90–6.
  • 31. Knight S, Luft J, Nakagawa S, Katzman WB. Comparisons of pelvic floor muscle performance, anxiety, quality of life and life stress in women with dry overactive bladder compared with asymptomatic women. BJU Int. 2012 Jun; 109(11):1685–9.

The Relationship Between Pelvic Floor Muscle Strength and Bladder Symptom Severity and Anxiety Level in Women with Overactive Bladder

Year 2018, Volume: 1 Issue: 2, 1 - 7, 31.01.2019

Abstract

Aim: The aim of this study
was to investigate the relationship between pelvic floor muscle strength (PFMS)
and bladder symptom severity and anxiety level in women with Overactive Bladder
(OAB).

Method: Forty women with OAB were included in the study. Physical and
clinic characteristics of the patients were recorded. The PFMS of the patients
with
perineometer,
symptoms severity related to OAB with Overactive Bladder-V8 Questionnaire
(OAB-V8), urgency with Patient Perception of Intensity of Urgency Score (PPIUS)
and anxiety level with Spielberger State Trait Anxiety Inventory were
evaluated.
Pearson and Spearman correlation tests
were used for analysis.

Results:
It was
found a moderate negative correlation between the PFMS and OAB-V8
(p < 0.001; r= -0.568), PPIUS (p= 0.004; r= -0.447) and trait anxiety scores (p= 0.010; r= -0.440). It was not detected a significant
correlation between the PFMS and state anxiety scores (p= 0.451; r= -0.134).

Conclusion: In this study, it was seen a negative correlation
between the PFMS and  symptoms severity
related to OAB, and trial anxiety level in women with OAB. It should be taken
into account increasing the PFMS in treatment of these patients for decreasing
the AAM symptoms and anxiety level.

References

  • 1. Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Neurourol Urodyn. 2010 Jan; 21(1):5-26.
  • 2. Irwin DE, Milsom I, Hunskaar S, Reilly K, Kopp Z, Herschorn S, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol. 2006 Dec; 50(6):1306–14.
  • 3. Milsom I, Abrams P, Cardozo L, Roberts RG, Thüroff J, Wein AJ. How wide spread are the symptoms of the overactive bladder and how are they managed? A population-based study. BJU Int. 2001 Jun; 87(9):760–6.
  • 4. Lugo Salcedo F, Sánchez Borrego R, Bueno ER, Sanz TO, García PB, Munné JG, C, et al. Assessment of female prevalence of overactive bladder (OAB) in Barcelona using a self-administered screening questionnaire: The Cuestionario de Autoevaluación del Control de la Vejiga (CACV). Int Urogynecol J. 2013 Sep; 24(9):1559-66.
  • 5. Mostwin JL. Pathophysiology: The varieties of bladder overactivity. Urology. 2002 Nov; 60(5):22-6.
  • 6. Gunnarsson M, Mattiasson A. Circumvaginal surface electromyography in women with urinary incontinence and in healthy volunteers. Scand J Urol Nephrol Suppl. 1994; 157:89-95.
  • 7. Gunnarsson M, Mattiasson A. Female stress, urge, and mixed urinary incontinence are associated with a chronic and progressive pelvic floor/vaginal neuromuscular disorder: an investigation of 317 healthy and incontinent women using vaginal surface electromyography. Neurourol Urodyn. 1999; 18(6):613-21.
  • 8. Shafik A, Shafik IA. Overactive bladder inhibition in response to pelvic floor muscle exercises. World J Urol. 2003 May; 20(6):374–7
  • 9. Artibani W. Diagnosis and significance of idiopathic overactive bladder. Urology. 1997 Dec; 50(6A Suppl):25–32
  • 10. Bo K, Berghmans LCM. Nonpharmacologic treatment for overactive bladder-pelvic floor exercises. Urology. 2000 May; 55(5A Suppl):7–11
  • 11. Lai H, Gardner V, Vetter J, Andriole GL. Correlation between psychological stress levels and the severity of overactive bladder symptoms. BMC Urol. 2015 Mar; 15:14.
  • 12. Çankaya A, Oskay ÜY. Assessment of bladder diaries of women diagnosed with overactive bladder syndrome. Gulhane Med J. 2014 Sep; 56(3):169-73.
  • 13. Patterson A. Behaviour change to treat overactive bladder syndrome. Nurs Times. 2011 Nov; 107(46):16-9.
  • 14. Freeman RM, Adekanmi OA. Overactive bladder. Best Pract Res Clin Obstet Gynaecol. 2005 Dec; 19(6):829–41.
  • 15. Wang Y, Xu K, Hu H, Zhang X, Wang X, Na Y, et al. Prevalence, risk factors, and impact on health related quality of life of overactive bladder in China. Neurourol Urodyn. 2011 Nov; 30(8):1448-55.
  • 16. Smith AL, Wein AJ. Contemporary management of overactive bladder. Postgrad Med. 2012 Jan; 124(1):104-16.
  • 17. Coyne K, Revicki D, Hunt T, Corey R, Stewart W, Bentkover J, et al. Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-q. Qual Life Res. 2002 Sep; 11(6):563-74.
  • 18. Tarcan T, Mangır N, Özgür MÖ, Akbal C. OAB-V8 aşırı aktif mesane sorgulama formu validasyon çalışması. Üroloji Bülteni. 2012; 21:113-6.
  • 19. Cartwright R, Srikrishna S, Cardozo L, Robinson D. Validity and reliability of the patient's perception of intensity of urgency scale in overactive bladder. BJU Int. 2011 May; 107(10):1612–7.
  • 20. Spielberger CD, Gorsuch RL, Lushene R. Manual for the state-trait anxiety inventory: STAI (“Self-evaluation Questionnaire”). Palo Alto: Consulting Psychologists Press; 1970.
  • 21. Öner N, Le Compte A. Süreksiz Durumluk ve Sürekli Kaygı Envanteri El Kitabı. 2. baskı. İstanbul, Türkiye: Boğaziçi Üniversitesi Yayınları; 1985.
  • 22. Wattanayingcharoenchai R, Manonai J, Vannatim N, Saritapirak S, Imsomboon C, Chittacharoen A. Impact of stress urinary incontinence and overactive bladder on quality of life in Thai women attending the urogynecology clinic. J Med Assoc Thai. 2007 Jan; 90(1):26-31.
  • 23. Lai HH, Rawal A, Shen B, Vetter J. The relationship between anxiety and overactive bladder or urinary incontinence symptoms in the clinical population. Urology. 2016 Dec; 98:50–7.
  • 24. Macaulay AJ, Stern RS, Holmes DM, Stanton SL. Micturition and the mind: psychological factors in the aetiology and treatment of urinary symptoms in women. Br Med J (Clin Res Ed). 1987 Feb; 294(6571):540-3.
  • 25. Melotti IGR, Juliato CRT, Tanaka M, Riccetto CLZ. Severe depression and anxiety in women with overactive bladder. Neurourol Urodyn. 2018 Jan; 37(1):223–8
  • 26. Kupelian V, Wei JT, O’Leary MP, Norgaard JP, Rosen RC, McKinlay JB. Nocturia and quality of life: results from the Boston area community health survey. Eur Urol. 2012 Jan; 61(1):78–84.
  • 27. Alves AT, Jácomo RH, Gomide LB, Garcia PA, Bontempo AP, Karnikoskwi MG. Relationship between anxiety and overactive bladder syndrome in older women. Rev Bras Ginecol Obstet. 2014 Jul; 36(7):1–9.
  • 28. Coyne KS, Sexton CC, Irwin DE, Kopp ZS, Kelleher CJ, Milsom I. The Impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, Work productivity, sexuality and emotional well-being in men and women: results from the EPIC study. BJU Int. 2008 Jun; 101(11):1388–95.
  • 29. Stewart WF, Van Rooyen JB, Cundif GW, Abrams P, Herzog AR, Corey R, et al. Prevalence of burden of overactive bladder in the United States. World J Urol. 2003 May; 20(6):327–36.
  • 30. Milsom I, Kaplan SA, Coyne KS, Sexton CC, Kopp ZS. Effect of bothersome overactivie bladder symptoms on health-related quality of life, anxiety, depression, and treatment seeking in the United States: results from EpiLUTS. Urology. 2012 Jul; 80(1):90–6.
  • 31. Knight S, Luft J, Nakagawa S, Katzman WB. Comparisons of pelvic floor muscle performance, anxiety, quality of life and life stress in women with dry overactive bladder compared with asymptomatic women. BJU Int. 2012 Jun; 109(11):1685–9.
There are 31 citations in total.

Details

Primary Language Turkish
Subjects Health Care Administration
Journal Section Articles
Authors

Şeyda Toprak Çelenay 0000-0001-6720-4452

Yasemin Karaaslan 0000-0001-5664-0849

Kemal Oskay This is me 0000-0003-0403-2432

Faruk Küçükdurmaz 0000-0002-7946-6916

Publication Date January 31, 2019
Published in Issue Year 2018 Volume: 1 Issue: 2

Cite

APA Toprak Çelenay, Ş., Karaaslan, Y., Oskay, K., Küçükdurmaz, F. (2019). Aşırı Aktif Mesaneli Kadınlarda Pelvik Taban Kas Kuvveti ile Mesane Semptom Ciddiyeti ve Kaygı Düzeyi Arasındaki İlişkisi. Türkiye Sağlık Bilimleri Ve Araştırmaları Dergisi, 1(2), 1-7.
AMA Toprak Çelenay Ş, Karaaslan Y, Oskay K, Küçükdurmaz F. Aşırı Aktif Mesaneli Kadınlarda Pelvik Taban Kas Kuvveti ile Mesane Semptom Ciddiyeti ve Kaygı Düzeyi Arasındaki İlişkisi. Türkiye Sağlık Bilimleri ve Araştırmaları Dergisi. January 2019;1(2):1-7.
Chicago Toprak Çelenay, Şeyda, Yasemin Karaaslan, Kemal Oskay, and Faruk Küçükdurmaz. “Aşırı Aktif Mesaneli Kadınlarda Pelvik Taban Kas Kuvveti Ile Mesane Semptom Ciddiyeti Ve Kaygı Düzeyi Arasındaki İlişkisi”. Türkiye Sağlık Bilimleri Ve Araştırmaları Dergisi 1, no. 2 (January 2019): 1-7.
EndNote Toprak Çelenay Ş, Karaaslan Y, Oskay K, Küçükdurmaz F (January 1, 2019) Aşırı Aktif Mesaneli Kadınlarda Pelvik Taban Kas Kuvveti ile Mesane Semptom Ciddiyeti ve Kaygı Düzeyi Arasındaki İlişkisi. Türkiye Sağlık Bilimleri ve Araştırmaları Dergisi 1 2 1–7.
IEEE Ş. Toprak Çelenay, Y. Karaaslan, K. Oskay, and F. Küçükdurmaz, “Aşırı Aktif Mesaneli Kadınlarda Pelvik Taban Kas Kuvveti ile Mesane Semptom Ciddiyeti ve Kaygı Düzeyi Arasındaki İlişkisi”, Türkiye Sağlık Bilimleri ve Araştırmaları Dergisi, vol. 1, no. 2, pp. 1–7, 2019.
ISNAD Toprak Çelenay, Şeyda et al. “Aşırı Aktif Mesaneli Kadınlarda Pelvik Taban Kas Kuvveti Ile Mesane Semptom Ciddiyeti Ve Kaygı Düzeyi Arasındaki İlişkisi”. Türkiye Sağlık Bilimleri ve Araştırmaları Dergisi 1/2 (January 2019), 1-7.
JAMA Toprak Çelenay Ş, Karaaslan Y, Oskay K, Küçükdurmaz F. Aşırı Aktif Mesaneli Kadınlarda Pelvik Taban Kas Kuvveti ile Mesane Semptom Ciddiyeti ve Kaygı Düzeyi Arasındaki İlişkisi. Türkiye Sağlık Bilimleri ve Araştırmaları Dergisi. 2019;1:1–7.
MLA Toprak Çelenay, Şeyda et al. “Aşırı Aktif Mesaneli Kadınlarda Pelvik Taban Kas Kuvveti Ile Mesane Semptom Ciddiyeti Ve Kaygı Düzeyi Arasındaki İlişkisi”. Türkiye Sağlık Bilimleri Ve Araştırmaları Dergisi, vol. 1, no. 2, 2019, pp. 1-7.
Vancouver Toprak Çelenay Ş, Karaaslan Y, Oskay K, Küçükdurmaz F. Aşırı Aktif Mesaneli Kadınlarda Pelvik Taban Kas Kuvveti ile Mesane Semptom Ciddiyeti ve Kaygı Düzeyi Arasındaki İlişkisi. Türkiye Sağlık Bilimleri ve Araştırmaları Dergisi. 2019;1(2):1-7.